Extensive colonic mucosal defect induced by mesalamine
Sign Up to like & getrecommendations! Published in 2018 at "Digestive Endoscopy"
DOI: 10.1111/den.13043
Abstract: Mesalamine is used as the first-line therapy for ulcerative colitis (UC). Although the exacerbation of symptoms of UC can occur in 2-4% of patients who are administered mesalamine (1-3), endoscopic features of the patients with… read more here.
Keywords: defect induced; induced mesalamine; colonic mucosal; mucosal defect ... See more keywords